Drug Repurposing for Glioblastoma and Current Advances in Drug Delivery—A Comprehensive Review of the Literature

Glioblastoma (GBM) is the most common primary malignant brain tumor in adults with an extremely poor prognosis. There is a dire need to develop effective therapeutics to overcome the intrinsic and acquired resistance of GBM to current therapies. The process of developing novel anti-neoplastic drugs...

Descripción completa

Detalles Bibliográficos
Autores principales: Alomari, Safwan, Zhang, Irma, Hernandez, Adrian, Kraft, Caitlin Y., Raj, Divyaansh, Kedda, Jayanidhi, Tyler, Betty
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699739/
https://www.ncbi.nlm.nih.gov/pubmed/34944514
http://dx.doi.org/10.3390/biom11121870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699739/
https://www.ncbi.nlm.nih.gov/pubmed/34944514
http://dx.doi.org/10.3390/biom11121870

Ejemplares similares